Blasi F - Search Results

1

Domain 1 of the urokinase receptor (uPAR) is required for uPAR-mediated cell binding to vitronectin.

Sidenius N, Blasi F. Sidenius N, et al. Among authors: blasi f. FEBS Lett. 2000 Mar 17;470(1):40-6. doi: 10.1016/s0014-5793(00)01282-5. FEBS Lett. 2000. PMID: 10722842 Free article.

2

Urokinase regulates vitronectin binding by controlling urokinase receptor oligomerization.

Sidenius N, Andolfo A, Fesce R, Blasi F. Sidenius N, et al. Among authors: blasi f. J Biol Chem. 2002 Aug 2;277(31):27982-90. doi: 10.1074/jbc.M111736200. Epub 2002 May 28. J Biol Chem. 2002. PMID: 12034711 Free article.

3

Urokinase-urokinase receptor interaction mediates an inhibitory signal for HIV-1 replication.

Alfano M, Sidenius N, Panzeri B, Blasi F, Poli G. Alfano M, et al. Among authors: blasi f. Proc Natl Acad Sci U S A. 2002 Jun 25;99(13):8862-7. doi: 10.1073/pnas.142078099. Proc Natl Acad Sci U S A. 2002. PMID: 12084931 Free PMC article.

4

Metalloproteases cleave the urokinase-type plasminogen activator receptor in the D1-D2 linker region and expose epitopes not present in the intact soluble receptor.

Andolfo A, English WR, Resnati M, Murphy G, Blasi F, Sidenius N. Andolfo A, et al. Among authors: blasi f. Thromb Haemost. 2002 Aug;88(2):298-306. Thromb Haemost. 2002. PMID: 12195704

5

The urokinase plasminogen activator system in cancer: recent advances and implication for prognosis and therapy.

Sidenius N, Blasi F. Sidenius N, et al. Among authors: blasi f. Cancer Metastasis Rev. 2003 Jun-Sep;22(2-3):205-22. doi: 10.1023/a:1023099415940. Cancer Metastasis Rev. 2003. PMID: 12784997 Review.

6

Metabolism of tumour-derived urokinase receptor and receptor fragments in cancer patients and xenografted mice.

Sier CF, Nicoletti I, Santovito ML, Frandsen T, Aletti G, Ferrari A, Lissoni A, Giavazzi R, Blasi F, Sidenius N. Sier CF, et al. Among authors: blasi f. Thromb Haemost. 2004 Feb;91(2):403-11. doi: 10.1160/TH03-06-0351. Thromb Haemost. 2004. PMID: 14961171

7

The urokinase receptor is overexpressed in the AIDS dementia complex and other neurological manifestations.

Cinque P, Nebuloni M, Santovito ML, Price RW, Gisslen M, Hagberg L, Bestetti A, Vago G, Lazzarin A, Blasi F, Sidenius N. Cinque P, et al. Among authors: blasi f. Ann Neurol. 2004 May;55(5):687-94. doi: 10.1002/ana.20076. Ann Neurol. 2004. PMID: 15122709

8

Expression of the urokinase plasminogen activator and its receptor in HIV-1-associated central nervous system disease.

Sidenius N, Nebuloni M, Sala S, Zerbi P, Price RW, Gisslen M, Hagberg L, Vago L, Lazzarin A, Blasi F, Cinque P. Sidenius N, et al. Among authors: blasi f. J Neuroimmunol. 2004 Dec;157(1-2):133-9. doi: 10.1016/j.jneuroim.2004.08.038. J Neuroimmunol. 2004. PMID: 15579290

9

Specific immunofluorimetric assay detecting the chemotactic epitope of the urokinase receptor (uPAR).

Resnati M, Pallavicini I, Daverio R, Sidenius N, Bonini P, Blasi F. Resnati M, et al. Among authors: blasi f. J Immunol Methods. 2006 Jan 20;308(1-2):192-202. doi: 10.1016/j.jim.2005.10.013. Epub 2005 Dec 19. J Immunol Methods. 2006. PMID: 16386755

10

Inhibition of HIV replication by the plasminogen activator is dependent on vitronectin-mediated cell adhesion.

Elia C, Cassol E, Sidenius N, Blasi F, Castagna A, Poli G, Alfano M. Elia C, et al. Among authors: blasi f. J Leukoc Biol. 2007 Nov;82(5):1212-20. doi: 10.1189/jlb.0407251. Epub 2007 Aug 17. J Leukoc Biol. 2007. PMID: 17704294

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,169 results

Search Page

Filters